| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:2634.)
© 2002 American Heart Association, Inc.
Editorial |
From the Department of Medicine, Division of Clinical Pharmacology, Karolinska Hospital and Institute, Stockholm, Sweden.
Correspondence to Professor Paul Hjemdahl, Department of Medicine, Division of Clinical Pharmacology, Karolinska Hospital and Institute, SE-171 76 Stockholm, Sweden. E-mail Paul.Hjemdahl@ks.se
Key Words: Editorials metabolism stress nervous system, autonomic
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Modern society has brought with it profound changes in lifestyle and an increased incidence of atherosclerotic vascular disease. Body weights are on the rise, diets are becoming less healthy, and people are becoming increasingly sedentary, resulting in elevations of blood pressure and metabolic alterations that increase atherothrombotic risk. In fact, obesity, insulin resistance, and diabetes are becoming a public health problem of epidemic proportions.1,2 In addition, modern society imposes demands on many that lead to difficulties in coping with their situations and more chronic "stress." Stress engages the central nervous system and activates behavioral and physiological response patterns, such as the "defense" and "defeat" reactions, which have been beneficial for the survival of the individual and the species but may become maladaptive when stress is chronic.35 The concepts of "allostasis," ie, adaptation to physiological states and the environment, and "allostatic load" are helpful in understanding how responses to stress may become maladaptive and damaging.5
See p 2659
Stress activates the sympathoadrenal system and the hypothalamic-pituitary-adrenocortical (HPA) axis. Defense reactions involve catecholamine release, vagal withdrawal, cortisol secretion, and activation of the renin-angiotensin system; the less well characterized defeat reaction is a stimulus for cortisol production.3,4 These mediators subserve functions that help the individual during short-term stress. When stress is frequent, adaptation (coping) is lacking, the ability to shut off the stress response is deficient, or the responses to stress are inadequate and compensatory mechanisms are activated, the allostatic load may become overwhelming and the adaptive processes become maladaptive.5 Stress is involved
Related Article:
Circulation 2002 106: 2659-2665.
This article has been cited by other articles:
![]() |
N. Ranjit, A. V. Diez-Roux, B. Sanchez, T. Seeman, S. Shea, S. Shrager, and K. Watson Association of Salivary Cortisol Circadian Pattern With Cynical Hostility: Multi-Ethnic Study of Atherosclerosis Psychosom Med, September 1, 2009; 71(7): 748 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ascione, C.A. Rogers, C. Rajakaruna, and G.D. Angelini Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery Circulation, July 8, 2008; 118(2): 113 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Futterman and L. Lemberg Inequalities in the Healthcare System: A Problem, Worldwide Am. J. Crit. Care., November 1, 2007; 16(6): 617 - 620. [Full Text] [PDF] |
||||
![]() |
D. Lucini, S. Riva, P. Pizzinelli, and M. Pagani Stress Management at the Worksite: Reversal of Symptoms Profile and Cardiovascular Dysregulation Hypertension, February 1, 2007; 49(2): 291 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, R. Niaura, J. R. Dyer, B.-J. Shen, J. F. Todaro, J. M. McCaffery, A. Spiro III, and K. D. Ward Hostility and Urine Norepinephrine Interact to Predict Insulin Resistance: The VA Normative Aging Study. Psychosom Med, September 1, 2006; 68(5): 718 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Innes, C. Bourguignon, and A. G. Taylor Risk Indices Associated with the Insulin Resistance Syndrome, Cardiovascular Disease, and Possible Protection with Yoga: A Systematic Review J Am Board Fam Med, November 1, 2005; 18(6): 491 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verma and E. T. H. Yeh C-reactive protein and atherothrombosis--Beyond a biomarker: an actual partaker of lesion formation Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1253 - R1256. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |